Inhibition of T-Cell activation by the CTLA4-Fc abatacept is sufficient to ameliorate proteinuric kidney disease

  1. Herrera, M.
  2. Söderberg, M.
  3. Sabirsh, A.
  4. Valastro, B.
  5. Mölne, J.
  6. Santamaria, B.
  7. Valverde, A.M.
  8. Guionaud, S.
  9. Heasman, S.
  10. Bigley, A.
  11. Jermutus, L.
  12. Rondinone, C.
  13. Coghlan, M.
  14. Baker, D.
  15. Quinn, C.M.
Revue:
American Journal of Physiology - Renal Physiology

ISSN: 1522-1466,  0363-6127

Année de publication: 2017

Volumen: 312

Número: 4

Pages: F748-F759

Type: Article

DOI: 10.1152/AJPRENAL.00179.2016 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus